Ground News

AbbVie image

News from AbbVie

Stay current with all the latest and breaking news about AbbVie, compare headlines and perspectives between news sources on stories happening today. In total, 67 stories have been published about AbbVie which Ground News has aggregated in the past 3 months.

Covered Most By

watchlistnews.com

Suggest a source

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top AbbVie News

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

AbbVie · Vancouver

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

100% Right coverage: 1 sources

VANCOUVER, British Columbia -- AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell engagers (TCE) in oncology. The expansion builds upon the successful partnership established in December 2022 and includes access to AbCellera’s TCE platform to develop therapeutic antibodies for tumor targets.See the Story

Redhawk Wealth Advisors Inc. Sells 64 Shares of AbbVie Inc. (NYSE:ABBV)

Redhawk Wealth Advisors Inc. Sells 64 Shares of AbbVie Inc. (NYSE:ABBV)

Redhawk Wealth Advisors Inc. lessened its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,545 shares of the company’s stock after selling 64 shares during the quarter. Redhawk Wealth Advisors Inc.’s holdings in AbbVie were worth $452,000 as of its most recent SEC filing. Several other hedge funds have also recently …See the Story

Compton Wealth Advisory Group LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Compton Wealth Advisory Group LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Compton Wealth Advisory Group LLC lowered its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,406 shares of the company’s stock after selling 221 shares during the quarter. Compton Wealth Advisory […]See the Story

Latest News Stories

Breaking News Topics Related to AbbVie